Get Social With Us

CHIs 4th Annual Biotherapeutics Analytical Summit

Demonstrating comparability is a key requirement throughout drug development. Dr. Sheila Magil will be presenting an overview of regulatory expectations for comparability as part of a short course​ entitled, “Comparability Protocols for Innovator Products and Biosimilars – Regulatory Expectations,” during CHI’s Fourth Annual Biotherapeutics Analytical Summit to be held from March 11-14, 2013 in Baltimore, MD.  To arrange a meeting with Sheila at the conference and to learn more about BPTC’s analytical expertise, please click here.